Back

Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation

25 August 2023 (08:15 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: epidemiology (1) Epidemiology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Zanfina Ademi

Monash University, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
The association of non-alcoholic fatty liver disease and advanced hepatic fibrosis with cardiovascular mortality in Taiwanese adults: a longitudinal cohort study
Ms X. Wei (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Social, behavioral, and metabolic risk factors for racial disparities in cardiovascular disease mortality in US adults
Professor J. He (New Orleans, US)
Abstract Slides Video
Presentation thumbnail
Kidney function and future risk of atherosclerotic cardiovascular disease: a study from, approximately half million adults
Doctor J. Rana (Oakland, US)
Abstract Slides Video
Presentation thumbnail
J-shaped association between serum uric acid levels and chronic kidney disease: a cross-sectional study using large health examination data
Doctor S. Kawasoe (Kagoshima, JP)
Abstract Slides Video
Presentation thumbnail
The impact of longitudinal changes in BMI and serum uric acid levels on new-onset atrial fibrillation
Doctor J. Munakata (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention: epidemiology (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Cost-effectiveness of statin therapy for primary prevention of cardiovascular disease based on different LDL-C targets: a modelling study
thumbnail
Congress Presentation
Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events
thumbnail
Congress Presentation
Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources